Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100

Agilent Technologies, Inc. (A) EPS (diluted)

Alert me on EPS (diluted)

Agilent Technologies, Inc.'s EPS (diluted) for fiscal 2025 was $4.57, unchanged from fiscal 2024. Over the twelve months to 31 July 2026 it was $5.08. Over the past ten years it has ranged from $0.97 (fiscal 2018) to $4.57 (fiscal 2025) — the current reading is the highest in ten years. EPS (diluted) has risen for 5 consecutive fiscal years. Agilent Technologies, Inc. ranks 12th of 52 Diagnostics & Research companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $4.57 3.16%
FY2024 $4.43 5.73%
FY2023 $4.19 0.24%
FY2022 $4.18 6.09%
FY2021 $3.94 71.30%
FY2020 $2.30 (31.75%)
FY2019 $3.37 247.42%
FY2018 $0.97 (53.81%)
FY2017 $2.10 50.00%
FY2016 $1.40 17.65%

Quarterly newest first

Period EPS (diluted) Change
Jul 2026 $1.28 6.67%
Apr 2026 $1.20 12.15%
Jan 2026 $1.07 (30.07%)
Oct 2025 $1.53 29.66%
43 more quarters

Against its own ten years

Low $0.97 High $4.57
Ten-year median $3.37
Current reading's percentile 100

EPS (diluted) against peers

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on A